Literature DB >> 31280323

Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at magnetic resonance imaging, and low-voltage areas in patients with persistent atrial fibrillation: comparison of imaging vs. electrical parameters of fibrosis and arrhythmogenesis.

Juan Chen1,2, Thomas Arentz1, Hubert Cochet3,4, Björn Müller-Edenborn1, Steven Kim5, Zoraida Moreno-Weidmann1, Jan Minners1, Peter Kohl6, Heiko Lehrmann1, Juergen Allgeier1, Dietmar Trenk1, Meleze Hocini3,4, Pierre Jais3,4, Michel Haissaguerre3,4, Amir Jadidi1.   

Abstract

AIMS: Atrial fibrosis contributes to arrhythmogenesis in atrial fibrillation and can be detected by MRI or electrophysiological mapping. The current study compares the spatial correlation between delayed enhancement (DE) areas to low-voltage areas (LVAs) and to arrhythmogenic areas with spatio-temporal dispersion (ST-Disp) or continuous activity (CA) in atrial fibrillation (AF). METHODS AND
RESULTS: Sixteen patients with persistent AF (nine long-standing) underwent DE-magnetic resonance imaging (1.25 mm × 1.25 mm × 2.5 mm) prior to pulmonary vein isolation. Left atrial (LA) voltage mapping was acquired in AF and the regional activation patterns of 7680 AF wavelets were analysed. Sites with ST-Disp or CA were characterized (voltage, duration) and their spatial relationship to DE areas and LVAs <0.5 mV was assessed. Delayed enhancement areas and LVAs covered 55% and 24% (P < 0.01) of total LA surface, respectively. Delayed enhancement area was present at 61% of LVAs, whereas low voltage was present at 28% of DE areas. Most DE areas (72%) overlapped with atrial high-voltage areas (>0.5 mV). Spatio-temporal dispersion and CA more frequently co-localized with LVAs than with DE areas (78% vs. 63%, P = 0.02). Regional bipolar voltage of ST-Disp vs. CA was 0.64 ± 0.47 mV vs. 0.58 ± 0.51 mV. All 28 ST-Disp and 56 CA areas contained electrograms with prolonged duration (115 ± 14 ms) displaying low voltage (0.34 ± 0.11 mV).
CONCLUSION: A small portion of DE areas and LVAs harbour the arrhythmogenic areas displaying ST-Disp or CA. Most arrhythmogenic activities co-localized with LVAs, while there was less co-localization with DE areas. There is an important mismatch between DE areas and LVAs which needs to be considered when used as target for catheter ablation. Published on behalf of the European Society of Cardiology. All rights creserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Substrate; Atrial fibrillation; Delayed enhancement magnetic resonance imaging; Low voltage; Rotational/focal trigger

Year:  2019        PMID: 31280323     DOI: 10.1093/europace/euz159

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  12 in total

Review 1.  An audit of uncertainty in multi-scale cardiac electrophysiology models.

Authors:  Richard H Clayton; Yasser Aboelkassem; Chris D Cantwell; Cesare Corrado; Tammo Delhaas; Wouter Huberts; Chon Lok Lei; Haibo Ni; Alexander V Panfilov; Caroline Roney; Rodrigo Weber Dos Santos
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2020-05-25       Impact factor: 4.226

2.  Extent of Left Atrial Fibrosis Correlates with Descending Aorta Proximity at 3D Late Gadolinium Enhancement Cardiac MRI in Patients with Atrial Fibrillation.

Authors:  Luuk H G A Hopman; Pranav Bhagirath; Mark J Mulder; Iris N Eggink; Albert C van Rossum; Cornelis P Allaart; Marco J W Götte
Journal:  Radiol Cardiothorac Imaging       Date:  2022-01-13

3.  Left Atrial Hypertension, Electrical Conduction Slowing, and Mechanical Dysfunction - The Pathophysiological Triad in Atrial Fibrillation-Associated Atrial Cardiomyopathy.

Authors:  Martin Eichenlaub; Bjoern Mueller-Edenborn; Jan Minners; Nikolaus Jander; Martin Allgeier; Heiko Lehrmann; Simon Schoechlin; Juergen Allgeier; Dietmar Trenk; Franz-Josef Neumann; Thomas Arentz; Amir Jadidi
Journal:  Front Physiol       Date:  2021-08-05       Impact factor: 4.566

Review 4.  Challenges Associated with Interpreting Mechanisms of AF.

Authors:  Caroline H Roney; Andrew L Wit; Nicholas S Peters
Journal:  Arrhythm Electrophysiol Rev       Date:  2020-02-12

Review 5.  Electrophysiological Consequences of Cardiac Fibrosis.

Authors:  Sander Verheule; Ulrich Schotten
Journal:  Cells       Date:  2021-11-18       Impact factor: 6.600

6.  Bi-atrial characterization of the electrical substrate in patients with atrial fibrillation.

Authors:  Tsitsinakis Giorgios; Frontera Antonio; Luca Rosario Limite; Lipartiti Felicia; David Zweiker; Manuela Cireddu; Kostantinos Vlachos; Alexios Hadjis; Giuseppe D'Angelo; Francesca Baratto; Caterina Bisceglia; Pasquale Vergara; Alessandra Marzi; Giovanni Peretto; Gabriele Paglino; Andrea Radinovic; Simone Gulletta; Simone Sala; Patrizio Mazzone; Paolo Della Bella
Journal:  Pacing Clin Electrophysiol       Date:  2022-04-23       Impact factor: 1.912

7.  Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.

Authors:  Zefeng Wang; Liting Cheng; Junmeng Zhang; Zhuo Liang; Ruiqing Dong; Fei Hang; Xinlu Wang; Ziyu Wang; Yongquan Wu; Jie Du
Journal:  Med Sci Monit       Date:  2020-09-08

8.  Epicardial box lesion using bipolar biparietal radiofrequency and multimodality scar evaluation-a case series.

Authors:  Geertruida Petronella Bijvoet; Sevasti-Maria Chaldoupi; Elham Bidar; Robert J Holtackers; Justin G L M Luermans; Bart Maesen
Journal:  Eur Heart J Case Rep       Date:  2021-12-27

9.  Echocardiographic diagnosis of atrial cardiomyopathy allows outcome prediction following pulmonary vein isolation.

Authors:  Martin Eichenlaub; Bjoern Mueller-Edenborn; Jan Minners; Martin Allgeier; Heiko Lehrmann; Juergen Allgeier; Dietmar Trenk; Franz-Josef Neumann; Nikolaus Jander; Thomas Arentz; Amir Jadidi
Journal:  Clin Res Cardiol       Date:  2021-04-29       Impact factor: 5.460

10.  Predictors of the voltage derived left atrial fibrosis in patients with long-standing persistent atrial fibrillation.

Authors:  Radoslaw M Kiedrowicz; Maciej Wielusinski; Andrzej Wojtarowicz; Jaroslaw Kazmierczak
Journal:  Cardiol J       Date:  2020-05-18       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.